Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Redcare Pharmacy NVSHPPF 67 Earnings per Share (Diluted) is $-2.45 as of Jun. 2026. GuruFocus rates SHPPF with a GF Score™ of 67/100 and a GF Value™ of $188.79 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Redcare Pharmacy NV ranks better than 65.02% on this metric.
Redcare Pharmacy NV's EPS (Basic) for the
three
months ended in Jun. 2026 was $0.27.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $-2.45.
During the past 3 years, the average EPS without NRIGrowth Rate was 23.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 1.70% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -2.10% per year.
During the past 13 years, Redcare Pharmacy NV's highest 3-Year average EPS without NRI Growth Rate was 23.50% per year. The lowest was -86.80% per year. And the median was -12.75% per year.
Redcare Pharmacy NV (OTCPK:SHPPF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Redcare Pharmacy NV Earnings per Share (Diluted) Related Terms
Redcare Pharmacy NV Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Redcare Pharmacy NV's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Redcare Pharmacy NV Earnings per Share (Diluted) Chart
Redcare Pharmacy NV Earnings per Share (Diluted) Competitor Comparison
For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redcare Pharmacy NV PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's PE Ratio distribution charts can be found below:
* The bar in red indicates where Redcare Pharmacy NV's PE Ratio falls into.
Redcare Pharmacy NV Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Redcare Pharmacy NV's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $-2.45 mean?
Redcare Pharmacy NV (SHPPF) has a Earnings per Share (Diluted) of $-2.45 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Redcare Pharmacy NV and its competitors. According to the industry distribution chart, Redcare Pharmacy NV ranks #177 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 35%.
Is Redcare Pharmacy NV's Earnings per Share (Diluted) too high?
Redcare Pharmacy NV's current Earnings per Share (Diluted) is $-2.45. Based on the distribution chart, Redcare Pharmacy NV ranks #177 out of 506 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Redcare Pharmacy NV has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's Earnings per Share (Diluted) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #177 out of 506 companies for Earnings per Share (Diluted). This puts Redcare Pharmacy NV in the upper half of its industry. The industry median Earnings per Share (Diluted) is 11.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.05, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Redcare Pharmacy NV and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redcare Pharmacy NV's current Earnings per Share (Diluted) is $-2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (SHPPF) is currently considered Possible Value Trap. The stock's GF Value™ is $188.79, compared to a current price of $64.80 — trading 65.7% below its estimated fair value. The current Earnings per Share (Diluted) is $-2.45. Redcare Pharmacy NV's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Redcare Pharmacy NV (SHPPF), the current Earnings per Share (Diluted) is $-2.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redcare Pharmacy NV (SHPPF) Overvalued in 2026?
Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued.
The current stock price of $64.80 is trading 65.7% below its estimated GF Value™ of $188.79.
GuruFocus considers Redcare Pharmacy NV to be Possible Value Trap.
Key valuation signals for SHPPF:
Earnings per Share (Diluted): $-2.45
GF Value™: $188.79 vs. price of $64.80 (65.7% below fair value)
No single metric tells the full story. See the SHPPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
67GF Score
Get the complete analysis for SHPPF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPPF has been successfully added to your 
